Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations

Abnormalities in Z-disc proteins cause hypertrophic (HCM), dilated (DCM) and/or restrictive cardiomyopathy (RCM), but disease-causing mechanisms are not fully understood. Myopalladin (MYPN) is a Z-disc protein expressed in striated muscle and functions as a structural, signaling and gene expression...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Purevjav, Enkhsaikhan (VerfasserIn) , Labeit, Siegfried (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January 27, 2012
In: Human molecular genetics
Year: 2012, Jahrgang: 21, Heft: 9, Pages: 2039-2053
ISSN:1460-2083
DOI:10.1093/hmg/dds022
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1093/hmg/dds022
Verlag, Volltext: https://academic.oup.com/hmg/article/21/9/2039/580000
Volltext
Verfasserangaben:Enkhsaikhan Purevjav, Takuro Arimura, Sibylle Augustin, Anne-Cecile Huby, Ken Takagi, Shinichi Nunoda, Debra L. Kearney, Michael D. Taylor, Fumio Terasaki, Johan M. Bos, Steve R. Ommen, Hiroki Shibata, Megumi Takahashi, Manatsu Itoh-Satoh, William J. McKenna, Ross T. Murphy, Siegfried Labeit, Yoichi Yamanaka, Noboru Machida, Jeong-Euy Park, Peta M. A. Alexander, Robert G. Weintraub, Yasushi Kitaura, Michael J. Ackerman, Akinori Kimura and Jeffrey A. Towbin

MARC

LEADER 00000caa a2200000 c 4500
001 1584490756
003 DE-627
005 20230427161329.0
007 cr uuu---uuuuu
008 181127s2012 xx |||||o 00| ||eng c
024 7 |a 10.1093/hmg/dds022  |2 doi 
035 |a (DE-627)1584490756 
035 |a (DE-576)514490756 
035 |a (DE-599)BSZ514490756 
035 |a (OCoLC)1341024418 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Purevjav, Enkhsaikhan  |e VerfasserIn  |0 (DE-588)1172301166  |0 (DE-627)1041101295  |0 (DE-576)514490918  |4 aut 
245 1 0 |a Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations  |c Enkhsaikhan Purevjav, Takuro Arimura, Sibylle Augustin, Anne-Cecile Huby, Ken Takagi, Shinichi Nunoda, Debra L. Kearney, Michael D. Taylor, Fumio Terasaki, Johan M. Bos, Steve R. Ommen, Hiroki Shibata, Megumi Takahashi, Manatsu Itoh-Satoh, William J. McKenna, Ross T. Murphy, Siegfried Labeit, Yoichi Yamanaka, Noboru Machida, Jeong-Euy Park, Peta M. A. Alexander, Robert G. Weintraub, Yasushi Kitaura, Michael J. Ackerman, Akinori Kimura and Jeffrey A. Towbin 
264 1 |c January 27, 2012 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.11.2018 
520 |a Abnormalities in Z-disc proteins cause hypertrophic (HCM), dilated (DCM) and/or restrictive cardiomyopathy (RCM), but disease-causing mechanisms are not fully understood. Myopalladin (MYPN) is a Z-disc protein expressed in striated muscle and functions as a structural, signaling and gene expression regulating molecule in response to muscle stress. MYPN was genetically screened in 900 patients with HCM, DCM and RCM, and disease-causing mechanisms were investigated using comparative immunohistochemical analysis of the patient myocardium and neonatal rat cardiomyocytes expressing mutant MYPN. Cardiac-restricted transgenic (Tg) mice were generated and protein–protein interactions were evaluated. Two nonsense and 13 missense MYPN variants were identified in subjects with DCM, HCM and RCM with the average cardiomyopathy prevalence of 1.66%. Functional studies were performed on two variants (Q529X and Y20C) associated with variable clinical phenotypes. Humans carrying the Y20C-MYPN variant developed HCM or DCM, whereas Q529X-MYPN was found in familial RCM. Disturbed myofibrillogenesis with disruption of α-actinin2, desmin and cardiac ankyrin repeat protein (CARP) was evident in rat cardiomyocytes expressing MYPNQ529X. Cardiac-restricted MYPNY20C Tg mice developed HCM and disrupted intercalated discs, with disturbed expression of desmin, desmoplakin, connexin43 and vinculin being evident. Failed nuclear translocation and reduced binding of Y20C-MYPN to CARP were demonstrated using in vitro and in vivo systems. MYPN mutations cause various forms of cardiomyopathy via different protein–protein interactions. Q529X-MYPN causes RCM via disturbed myofibrillogenesis, whereas Y20C-MYPN perturbs MYPN nuclear shuttling and leads to abnormal assembly of terminal Z-disc within the cardiac transitional junction and intercalated disc. 
700 1 |a Labeit, Siegfried  |d 1960-  |e VerfasserIn  |0 (DE-588)1033566837  |0 (DE-627)741562375  |0 (DE-576)381187314  |4 aut 
773 0 8 |i Enthalten in  |t Human molecular genetics  |d Oxford : Oxford Univ. Press, 1992  |g 21(2012), 9, Seite 2039-2053  |h Online-Ressource  |w (DE-627)269532722  |w (DE-600)1474816-2  |w (DE-576)082435243  |x 1460-2083  |7 nnas  |a Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations 
773 1 8 |g volume:21  |g year:2012  |g number:9  |g pages:2039-2053  |g extent:15  |a Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations 
856 4 0 |u http://dx.doi.org/10.1093/hmg/dds022  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://academic.oup.com/hmg/article/21/9/2039/580000  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181127 
993 |a Article 
994 |a 2012 
998 |g 1033566837  |a Labeit, Siegfried  |m 1033566837:Labeit, Siegfried  |d 60000  |d 61600  |d 50000  |e 60000PL1033566837  |e 61600PL1033566837  |e 50000PL1033566837  |k 0/60000/  |k 1/60000/61600/  |k 0/50000/  |p 17 
999 |a KXP-PPN1584490756  |e 3034153627 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1584490756","origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"January 27, 2012"}],"id":{"eki":["1584490756"],"doi":["10.1093/hmg/dds022"]},"physDesc":[{"extent":"15 S."}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"HMG online"}],"recId":"269532722","origin":[{"publisherPlace":"Oxford","publisher":"Oxford Univ. Press","dateIssuedDisp":"1992-","dateIssuedKey":"1992"}],"note":["Gesehen am 01.12.2020"],"disp":"Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutationsHuman molecular genetics","id":{"eki":["269532722"],"issn":["1460-2083"],"zdb":["1474816-2"]},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1992 -"],"language":["eng"],"part":{"text":"21(2012), 9, Seite 2039-2053","year":"2012","volume":"21","issue":"9","extent":"15","pages":"2039-2053"},"title":[{"subtitle":"HMG online","title":"Human molecular genetics","title_sort":"Human molecular genetics"}]}],"note":["Gesehen am 27.11.2018"],"name":{"displayForm":["Enkhsaikhan Purevjav, Takuro Arimura, Sibylle Augustin, Anne-Cecile Huby, Ken Takagi, Shinichi Nunoda, Debra L. Kearney, Michael D. Taylor, Fumio Terasaki, Johan M. Bos, Steve R. Ommen, Hiroki Shibata, Megumi Takahashi, Manatsu Itoh-Satoh, William J. McKenna, Ross T. Murphy, Siegfried Labeit, Yoichi Yamanaka, Noboru Machida, Jeong-Euy Park, Peta M. A. Alexander, Robert G. Weintraub, Yasushi Kitaura, Michael J. Ackerman, Akinori Kimura and Jeffrey A. Towbin"]},"person":[{"given":"Enkhsaikhan","role":"aut","display":"Purevjav, Enkhsaikhan","family":"Purevjav"},{"role":"aut","given":"Siegfried","display":"Labeit, Siegfried","family":"Labeit"}],"title":[{"title_sort":"Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations","title":"Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations"}],"language":["eng"]} 
SRT |a PUREVJAVENMOLECULARB2720